Torsilax Neo Química

Torsilax is a well-known Brazilian pharmaceutical product manufactured by Neo Química. It is a combined medication containing caffeine, carisoprodol, diclofenac sodium, and paracetamol, primarily used for treating musculoskeletal pain, rheumatism, and inflammatory conditions.

Neo Química was founded in 1959 in Brazil and became a significant player in the generic and over-the-counter medicine market. In 2009, the brand was acquired by Hypermarcas (now known as Hypera Pharma) for approximately $751 million. Today, Neo Química is one of the most prominent brands in Hypera Pharma's portfolio, and the company maintains a large-scale manufacturing operation in Anápolis, Goiás, which is considered the largest pharmaceutical industrial complex in Latin America.